Henry Schein UK announced today the expansion of the company’s CRITERION® brand, which includes gloves as well as soon a head-to-toe line of personal protective equipment...
New York- Pfizer Inc. has announced promising topline data from its Phase 2b clinical trial (NCT04707313) evaluating the oral Glucagon-like peptide-1 receptor agonist (GL...
